Literature DB >> 9775396

Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study.

S B Wharton1, K K Chan, F A Hamilton, J R Anderson.   

Abstract

The oligodendroglioma has been considered to be a tumour showing oligodendrocyte differentiation, but studies of the expression of oligodendrocyte markers have not conclusively demonstrated this and the pattern of differentiation of this tumour remains uncertain. Recent studies have suggested that some oligodendrogliomas may show neuronal differentiation. The aim of this study was to determine whether there was evidence of neuronal differentiation in a series of oligodendrogliomas, and, if so, to determine whether this identified a biologically or clinically distinct group. Immunohistochemistry was carried out on paraffin sections using antibodies to synaptophysin, phosphorylated and non-phosphorylated neurofilament proteins. An archival series of 32 oligodendrogliomas had been previously characterized for histological features, histological grade, Ki-67 labelling index, apoptosis index and prognosis. Six per cent of tumours showed expression of synaptophysin. Thirty-one per cent of cases showed expression of neurofilament proteins with an antibody to non-phosphorylated epitopes, but no cases were positive with antibodies to phosphorylated neurofilament epitopes. Tumours showing expression of neuronal markers did not show a difference in the distribution of histological grade or GFAP expression from those which did not express these markers, and there was no difference in labelling indices or prognosis between the two groups. In conclusion, a subset of oligodendrogliomas showed expression of neuronal lineage markers; this is discussed in relation to histogenesis and differential diagnosis. The expression of such markers did not identify a biologically or clinically distinct subgroup.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9775396     DOI: 10.1046/j.1365-2990.1998.00132.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  11 in total

1.  Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor.

Authors:  Addisalem T Makuria; Fraser C Henderson; Elisabeth J Rushing; Dan-Paul Hartmann; Norio Azumi; Metin Ozdemirli
Journal:  J Neurooncol       Date:  2006-10-13       Impact factor: 4.130

2.  Spinal cord glioneuronal tumor with neuropil-like islands with 1p/19q deletion in an adult with low-grade cerebral oligodendroglioma.

Authors:  Tyler J Fraum; Stephanie Barak; Svetlana Pack; Russell R Lonser; Howard A Fine; Martha Quezado; Fabio M Iwamoto
Journal:  J Neurooncol       Date:  2011-11-15       Impact factor: 4.130

3.  So-called malignant and extra-ventricular neurocytomas: reality or wrong diagnosis? A critical review about two overdiagnosed cases.

Authors:  A V Vallat-Decouvelaere; P Gauchez; P Varlet; M B Delisle; M Popovic; H Boissonnet; M Gigaud; J Mikol; J Hassoun
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

4.  Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex.

Authors:  Marjolein de Groot; Sjoukje T Toering; Karin Boer; Wim G M Spliet; Jan J Heimans; Eleonora Aronica; Jaap C Reijneveld
Journal:  Neuro Oncol       Date:  2010-01-06       Impact factor: 12.300

5.  Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.

Authors:  Arie Perry; Stephanie S Burton; Gregory N Fuller; Christopher A Robinson; Cheryl A Palmer; Lothar Resch; Eileen H Bigio; Meena Gujrati; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

6.  Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.

Authors:  Hiroaki Takeuchi; Toshihiko Kubota; Ryuhei Kitai; Ken Matsuda; Norichika Hashimoto; Kazufumi Sato
Journal:  J Neurooncol       Date:  2008-09-10       Impact factor: 4.130

7.  Prognostic significance of neuronal marker expression in glioblastomas.

Authors:  Kyung-Hwa Lee; Kyung-Joo Kang; Kyung-Sub Moon; Tae-Young Jung; Shin Jung; Jae-Hyoo Kim; Hyung-Seok Kim; Min-Cheol Lee
Journal:  Childs Nerv Syst       Date:  2012-08-26       Impact factor: 1.475

8.  Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

Authors:  Toru Kondo; Takao Setoguchi; Tetsuya Taga
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

9.  Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.

Authors:  Fausto J Rodriguez; Renan A Mota; Bernd W Scheithauer; Caterina Giannini; Hilary Blair; Kent C New; Kevin J Wu; Dennis W Dickson; Robert B Jenkins
Journal:  Brain Pathol       Date:  2008-08-15       Impact factor: 6.508

10.  Differential hypermethylation of death-associated protein kinase promoter in central neurocytoma and oligodendroglioma.

Authors:  Chia-Li Chung; Hung Pei Tsai; Cheng-Yu Tsai; Wan-Tzu Chen; Ann-Shung Lieu; Chih-Jen Wang; Jason Sheehan; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.